CB₁ modulation of hormone secretion, neuronal activation and mRNA expression following extracellular volume expansion : Endocannabinoids signalling in healthy and diseased brainRUGINSK, S. G; UCHOA, E. T; ELIAS, L. L. K et al.Experimental neurology (Print). 2010, Vol 224, Num 1, pp 114-122, issn 0014-4886, 9 p.Article

Unravelling the complex dissociation of [³H]-rimonabant from plated CB₁ cannabinoid receptor-expressing cellsWENNERBERG, M; BALENDRAN, A; CLAPHAM, J. C et al.Fundamental & clinical pharmacology. 2010, Vol 24, Num 2, pp 181-187, issn 0767-3981, 7 p.Article

Pain as a reward: Changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systemsBENEDETTI, Fabrizio; THOEN, Wilma; BLANCHARD, Catherine et al.Pain (Amsterdam). 2013, Vol 154, Num 3, pp 361-367, issn 0304-3959, 7 p.Article

Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-mazePENG HUANG; LIU-CHEN, Lee-Yuan; KIRBY, Lynn G et al.Neuroscience letters. 2010, Vol 475, Num 3, pp 165-168, issn 0304-3940, 4 p.Article

CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant)RAFFA, R. B; WARD, S. J.Journal of clinical pharmacy and therapeutics (Print). 2012, Vol 37, Num 3, pp 260-265, issn 0269-4727, 6 p.Article

Validated Stability-Indicating RP-HPLC Method for the Determination of Rimonabant in a Pharmaceutical Dosage FormHURTADO, Felipe K; RAVANELLO, Anne; AREND, Marcela Z et al.Journal of AOAC International. 2010, Vol 93, Num 3, pp 869-875, issn 1060-3271, 7 p.Article

Rimonabant chez le diabétique obèse : L'étude rio-diabetes confirme son intérêtCHAGNON, André.Concours médical (Paris). 2007, Vol 129, Num 19-20, pp 611-611, issn 0010-5309, 1 p.Article

How inverse can a neutral antagonist be? Strategic questions after the rimonabant issueGIRALDO, Jesús.Drug discovery today. 2010, Vol 15, Num 11-12, pp 411-415, issn 1359-6446, 5 p.Article

Rimonabant : A cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factorsGELFAND, Eli V; CANNON, Christopher P.Journal of the American College of Cardiology. 2006, Vol 47, Num 10, pp 1919-1926, issn 0735-1097, 8 p.Article

Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonistsMCLAUGHLIN, P. J; WINSTON, K. M; SWEZEY, L. A et al.Pharmacology, biochemistry and behavior. 2010, Vol 96, Num 1, pp 75-81, issn 0091-3057, 7 p.Article

Bioactivation Pathways of the Cannabinoid Receptor 1 Antagonist RimonabantANDRESEN BERGSTRÖM, Moa; ISIN, Emre M; CASTAGNOLI, Neal et al.Drug metabolism and disposition. 2011, Vol 39, Num 10, pp 1823-1832, issn 0090-9556, 10 p.Article

Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cellsMALFITANO, A. M; LAEZZA, C; PISANTI, S et al.British journal of pharmacology. 2008, Vol 153, Num 5, pp 1003-1010, issn 0007-1188, 8 p.Article

Cannabinoid Type 1 Receptor : Another Arrow in the Adipocytes' BowBELLOCCHIO, L; CERVINO, C; VICENNATI, V et al.Journal of neuroendocrinology. 2008, Vol 20, pp 130-138, issn 0953-8194, 9 p., SUP1Conference Paper

Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibitionORIO, L; CRESPO, I; LOPEZ-MORENO, J. A et al.Pharmacology, biochemistry and behavior. 2011, Vol 98, Num 2, pp 220-226, issn 0091-3057, 7 p.Article

Antagonism of Δ⁹-THC induced behavioral effects by rimonabant: Time course studies in ratsJÄRBE, Torbjörn U. C; GIFFORD, Roger S; MAKRIYANNIS, Alexandros et al.European journal of pharmacology. 2010, Vol 648, Num 1-3, pp 133-138, issn 0014-2999, 6 p.Article

The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in ratsSINK, K. S; SEGOVIA, K. N; COLLINS, L. E et al.Pharmacology, biochemistry and behavior. 2010, Vol 95, Num 4, pp 479-484, issn 0091-3057, 6 p.Article

Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in ratsKELSEY, John E; CALABRO, Siena.Psychopharmacologia. 2008, Vol 198, Num 4, pp 461-466, issn 0033-3158, 6 p.Article

Peripheral Endocannabinoid System-Mediated Actions of Rimonabant on Growth Hormone Secretion are Ghrelin-DependentAL-MASSADI, O; GABELLIERI, E; TRUJILLO, M. L et al.Journal of neuroendocrinology. 2010, Vol 22, Num 11, pp 1127-1136, issn 0953-8194, 10 p.Article

Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processesBURA, S. A; CASTANE, A; LEDENT, C et al.British journal of pharmacology. 2007, Vol 150, Num 6, pp 758-765, issn 0007-1188, 8 p.Article

CB1 cannabinoid receptor expression is regulated by glucose and feeding in rat pancreatic isletsVILCHES-FLORES, Alonso; DELGADO-BUENROSTRO, Norma Laura; NAVARRETE-VAZQUEZ, Gabriel et al.Regulatory peptides. 2010, Vol 163, Num 1-3, pp 81-87, issn 0167-0115, 7 p.Article

Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527 : Effects on food-reinforced behavior and comparisons with AM4113SINK, K. S; VEMURI, V. K; WOOD, J et al.Pharmacology, biochemistry and behavior. 2009, Vol 91, Num 3, pp 303-306, issn 0091-3057, 4 p.Article

Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in SchizophreniaLEVIN, Raquel; ALMEIDA, Valeria; COSTHEK ABILIO, Vanessa et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4960-4965, issn 1381-6128, 6 p.Article

Le système endocannabinoïde : des effets métaboliques aux effets neuroendocriniens = Endocannabinoid system : from metabolic to neuroendocrine effectsBRICAIRE, L; BRUE, T.Annales d'endocrinologie. 2007, Vol 68, issn 0003-4266, S12-S17, SUP1Article

Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptorsDO MONTE, Fabricio H; SOUZA, Rimenez R; BITENCOURT, Rafael M et al.Behavioural brain research. 2013, Vol 250, pp 23-27, issn 0166-4328, 5 p.Article

Discriminative stimulus functions of methanandamide and Δ⁹-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanolJÄRBE, Torbjörn U. C; CHEN LI; VADIVEL, Subramanian K et al.Psychopharmacologia. 2010, Vol 208, Num 1, pp 87-98, issn 0033-3158, 12 p.Article